APA

Ramachandran G., Hemanth Kumar A. K., Rajasekaran S., Kumar P., Ramesh K., Anitha S., Narendran G., Menon P., Gomathi C. & Swaminathan S. (20090519). CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India. : Antimicrobial agents and chemotherapy.

Chicago

Ramachandran Geetha, Hemanth Kumar A K, Rajasekaran Sikhamani, Kumar P, Ramesh K, Anitha S, Narendran G, Menon Pradeep, Gomathi C and Swaminathan Soumya. 20090519. CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India. : Antimicrobial agents and chemotherapy.

Harvard

Ramachandran G., Hemanth Kumar A. K., Rajasekaran S., Kumar P., Ramesh K., Anitha S., Narendran G., Menon P., Gomathi C. and Swaminathan S. (20090519). CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India. : Antimicrobial agents and chemotherapy.

MLA

Ramachandran Geetha, Hemanth Kumar A K, Rajasekaran Sikhamani, Kumar P, Ramesh K, Anitha S, Narendran G, Menon Pradeep, Gomathi C and Swaminathan Soumya. CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India. : Antimicrobial agents and chemotherapy. 20090519.